This consultation should cover your current thyroid function status, levothyroxine dose stability, and any relevant medical history
However, its use in the general population for weight management or body composition enhancement is not supported by sufficient evidence and falls outside its licensed indications in all countries where it holds authorisation
For patients with MCAS specifically, what piqued my interest in giving this class of medications a try was a case series in The American Journal of the Medical Sciences from mast cell experts, including doctors Afrin, Weinstock and Dempsey
The market is experiencing robust growth driven by the increasing burden of metabolic disorders, particularly diabetes and obesity, across both developed and emerging economies
This new approach could mean bigger changes for weight management than what weve seen so far